secwatch.observer — SEC 8-K summary
======================================

Issuer:     Carisma Therapeutics Inc. (CARM)
CIK:        0001485003
Form:       8-K
Filed at:   2025-04-16T23:59:59+00:00
Accession:  0001104659-25-035517
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Carisma receives Nasdaq delisting notice for MVLS, MVPHS, bid price non-compliance
--------------------------------------------------------------------------------

- Nasdaq notified Carisma on April 10, 2025, of delisting for failing to maintain $50M MVLS by April 8, 2025 compliance deadline.
- Company also failed $15M MVPHS rule; granted 180 days until October 7, 2025, to regain compliance.
- Existing bid price non-compliance (below $1.00) has compliance period through July 7, 2025.
- Carisma plans to request a hearing before Nasdaq Panel to stay delisting; no assurance of extension.
- Company considering all options but cannot guarantee regaining compliance with any listing rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925035517/0001104659-25-035517-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1485003/000110465925035517/tm2512481d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-035517

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer